Tenet Healthcare Corporation $THC Shares Sold by Teacher Retirement System of Texas

Teacher Retirement System of Texas decreased its position in shares of Tenet Healthcare Corporation (NYSE:THC) by 29.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 42,384 shares of the company’s stock after selling 17,293 shares during the quarter. Teacher Retirement System of Texas’ holdings in Tenet Healthcare were worth $7,460,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. US Bancorp DE grew its stake in shares of Tenet Healthcare by 0.8% during the 1st quarter. US Bancorp DE now owns 8,620 shares of the company’s stock worth $1,159,000 after purchasing an additional 68 shares during the period. Farther Finance Advisors LLC grew its stake in shares of Tenet Healthcare by 2.8% during the 2nd quarter. Farther Finance Advisors LLC now owns 2,615 shares of the company’s stock worth $460,000 after purchasing an additional 70 shares during the period. Lindbrook Capital LLC raised its stake in shares of Tenet Healthcare by 5.3% during the 1st quarter. Lindbrook Capital LLC now owns 1,427 shares of the company’s stock worth $192,000 after buying an additional 72 shares during the period. Signaturefd LLC raised its stake in shares of Tenet Healthcare by 11.2% during the 2nd quarter. Signaturefd LLC now owns 732 shares of the company’s stock worth $129,000 after buying an additional 74 shares during the period. Finally, Vista Investment Partners LLC raised its stake in shares of Tenet Healthcare by 0.3% during the 2nd quarter. Vista Investment Partners LLC now owns 25,257 shares of the company’s stock worth $4,445,000 after buying an additional 76 shares during the period. Institutional investors and hedge funds own 95.44% of the company’s stock.

Analyst Upgrades and Downgrades

THC has been the subject of several research analyst reports. JPMorgan Chase & Co. upped their target price on Tenet Healthcare from $190.00 to $200.00 and gave the stock an “overweight” rating in a research note on Monday, August 4th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Tenet Healthcare in a research note on Wednesday, October 8th. Mizuho upped their target price on Tenet Healthcare from $194.00 to $225.00 and gave the stock an “outperform” rating in a research note on Friday, October 17th. Wall Street Zen raised Tenet Healthcare from a “hold” rating to a “strong-buy” rating in a research note on Saturday, July 26th. Finally, Robert W. Baird reduced their price objective on Tenet Healthcare from $195.00 to $167.00 and set a “neutral” rating for the company in a research note on Friday, July 25th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $225.31.

Tenet Healthcare Stock Down 0.5%

Shares of THC opened at $208.00 on Friday. Tenet Healthcare Corporation has a 52-week low of $109.82 and a 52-week high of $217.43. The company has a market capitalization of $18.38 billion, a PE ratio of 14.26, a price-to-earnings-growth ratio of 0.89 and a beta of 1.52. The stock has a fifty day simple moving average of $195.30 and a two-hundred day simple moving average of $172.15. The company has a quick ratio of 1.63, a current ratio of 1.71 and a debt-to-equity ratio of 2.27.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Tuesday, October 28th. The company reported $3.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.33 by $0.37. Tenet Healthcare had a return on equity of 25.11% and a net margin of 6.49%.The business had revenue of $5.29 billion during the quarter, compared to the consensus estimate of $5.26 billion. During the same period last year, the company earned $2.93 EPS. The company’s revenue for the quarter was up 3.2% on a year-over-year basis. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. As a group, equities analysts forecast that Tenet Healthcare Corporation will post 12.24 EPS for the current year.

Insiders Place Their Bets

In other news, Director Christopher S. Lynch sold 3,952 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $176.39, for a total transaction of $697,093.28. Following the completion of the transaction, the director directly owned 12,358 shares in the company, valued at approximately $2,179,827.62. This represents a 24.23% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Saumya Sutaria sold 78,762 shares of the stock in a transaction on Wednesday, September 10th. The stock was sold at an average price of $190.78, for a total value of $15,026,214.36. Following the transaction, the chief executive officer owned 368,683 shares of the company’s stock, valued at approximately $70,337,342.74. This represents a 17.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 90,722 shares of company stock valued at $17,161,015 in the last three months. 0.81% of the stock is currently owned by insiders.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.